Ivosidenib (AG-120) Induced Durable Remissions and Transfusion Independence in Patients with IDH1-Mutant Untreated AML: Results from a Phase 1 Dose Escalation and Expansion Study
G. Roboz, C. Dinardo, E. Stein, S. Botton, A. Mims, G. Prince, J. Altman, M. Arellano, W. Donnellan, H. Erba, G. Mannis, D. Pollyea, A. Stein, G. Uy, J. Watts, A. Fathi, H. Kantarjian, M. Tallman, S. Choe, D. Dai, Bin Fan, Hongfang Wang, V. Zhang, K. Yen, S. Kapsalis, D. Hickman, Hua Liu, S. Agresta, Bin Wu, E. Attar, R. Stone
Blood